GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Mirlet7f2 | increases expression | EXP | | 6480464 | CTD | Doxorubicin results in increased expression of MIRLET7F-2 mRNA | PMID:31570982 | Mirlet7f2 | multiple interactions | EXP | | 6480464 | CTD | Doxorubicin affects the reaction [MIRLET7F-2 mRNA affects the localization of HAX1 protein]; Doxorubicin promotes the reaction [MIRLET7F-2 mRNA results in decreased expression of XPO1 mRNA]; Doxorubicin promotes the reaction [MIRLET7F-2 mRNA results in decreased expression of XPO1 protein]; Doxorubicin promotes the reaction [MIRLET7F-2 mRNA results in increased cleavage of CASP3 protein]; Doxorubicin promotes the reaction [MIRLET7F-2 mRNA results in increased cleavage of CASP9 protein]; MIRLET7F-2 mRNA affects the reaction [Doxorubicin affects the localization of HAX1 protein]; MIRLET7F-2 mRNA affects the reaction [Doxorubicin results in decreased expression of XPO1 protein]; MIRLET7F-2 mRNA affects the reaction [Doxorubicin results in increased cleavage of CASP3 protein]; MIRLET7F-2 mRNA affects the reaction [Doxorubicin results in increased cleavage of CASP9 protein]; MIRLET7F-2 mRNA inhibits the reaction [NEAT1 mRNA inhibits the reaction [Doxorubicin results in decreased expression of XPO1 mRNA]]; MIRLET7F-2 mRNA inhibits the reaction [NEAT1 mRNA inhibits the reaction [Doxorubicin results in decreased expression of XPO1 protein]]; NEAT1 mRNA inhibits the reaction [Doxorubicin results in increased expression of MIRLET7F-2 mRNA] | PMID:31570982 | | ||||||||||||||||||||||
| Go Back to source page | Continue to Ontology report |